Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrizia Popoli

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 7, 2002
Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatumPatrizia Popoli, Annita Pintor, Maria Rosaria Domenici, et al.
Behavioural Brain Research|November 17, 2009
Striatal 6-OHDA lesion in mice: Investigating early neurochemical changes underlying Parkinson's diseaseIgor Branchi, Ivana D'Andrea, Monica Armida, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2002
Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal functionSergi Ferré, Marzena Karcz-Kubicha, Bruce T Hope, et al.
Recenti Progressi in Medicina|March 22, 2022
[Unmet clinical need and new therapeutic options.]Francesca Caprari, Alessandro Alfano, Giuliano Buzzetti, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 18, 2003
Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administrationMarzena Karcz-Kubicha, Katerina Antoniou, Anton Terasmaa, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 2, 2003
A dual role of adenosine A2A receptors in 3-nitropropionic acid-induced striatal lesions: implications for the neuroprotective potential of A2A antagonistsDavid Blum, Marie-Christine Galas, Annita Pintor, et al.
Plos Genetics|November 22, 2008
A role for oxidized DNA precursors in Huntington's disease-like striatal neurodegenerationGabriele De Luca, Maria Teresa Russo, Paolo Degan, et al.
Aging Cell|May 8, 2013
Prolonged lifespan with enhanced exploratory behavior in mice overexpressing the oxidized nucleoside triphosphatase hMTH1Gabriele De Luca, Ilenia Ventura, Valentina Sanghez, et al.
Neurobiology of Disease|January 15, 2005
Minocycline in phenotypic models of Huntington's diseaseKadiombo Bantubungi, Carine Jacquard, Anita Greco, et al.
Journal of Neurochemistry|June 11, 2004
Neuroprotective effects of the mGlu5R antagonist MPEP towards quinolinic acid-induced striatal toxicity: involvement of pre- and post-synaptic mechanisms and lack of direct NMDA blocking activityPatrizia Popoli, Annita Pintor, Maria Teresa Tebano, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 7, 2002
Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatumPatrizia Popoli, Annita Pintor, Maria Rosaria Domenici, et al.
Behavioural Brain Research|November 17, 2009
Striatal 6-OHDA lesion in mice: Investigating early neurochemical changes underlying Parkinson's diseaseIgor Branchi, Ivana D'Andrea, Monica Armida, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2002
Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal functionSergi Ferré, Marzena Karcz-Kubicha, Bruce T Hope, et al.
Recenti Progressi in Medicina|March 22, 2022
[Unmet clinical need and new therapeutic options.]Francesca Caprari, Alessandro Alfano, Giuliano Buzzetti, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 18, 2003
Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administrationMarzena Karcz-Kubicha, Katerina Antoniou, Anton Terasmaa, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 2, 2003
A dual role of adenosine A2A receptors in 3-nitropropionic acid-induced striatal lesions: implications for the neuroprotective potential of A2A antagonistsDavid Blum, Marie-Christine Galas, Annita Pintor, et al.
Plos Genetics|November 22, 2008
A role for oxidized DNA precursors in Huntington's disease-like striatal neurodegenerationGabriele De Luca, Maria Teresa Russo, Paolo Degan, et al.
Aging Cell|May 8, 2013
Prolonged lifespan with enhanced exploratory behavior in mice overexpressing the oxidized nucleoside triphosphatase hMTH1Gabriele De Luca, Ilenia Ventura, Valentina Sanghez, et al.
Neurobiology of Disease|January 15, 2005
Minocycline in phenotypic models of Huntington's diseaseKadiombo Bantubungi, Carine Jacquard, Anita Greco, et al.
Journal of Neurochemistry|June 11, 2004
Neuroprotective effects of the mGlu5R antagonist MPEP towards quinolinic acid-induced striatal toxicity: involvement of pre- and post-synaptic mechanisms and lack of direct NMDA blocking activityPatrizia Popoli, Annita Pintor, Maria Teresa Tebano, et al.
Pageof 10